Despite Oil Rally, Only the Strong Will Survive: 4 to Buy Now
The oil services trade is still a contrarian one, to say the least. Oil seems to have hit bottom and turned higher, and that's a plus.
All Work
Lee Jackson
3 Networking Stocks to Buy That Could Post Big Earnings Soon
While SunTrust Robinson Humphrey concedes that the macro environment is somewhat uncertain and currency headwinds still have an impact on earnings, three top networking companies are outstanding buys now.
UBS Has 4 Safe Blue Chip Dividends to Buy, Even If the Market Has Topped
Solid growth stocks that pay good dividends make sense, especially when they all pay higher dividends than the current 30-year U.S. Treasury bond.
3 Cell Tower Stocks With Huge New Network Upside Potential for 2016
The mobile data demand growth is only going to continue to accelerate, and these three top companies are the best way for aggressive accounts to play a space that should just stay on fire.
Top Analyst Says Buy This Fastest-Growing Enterprise Technology Company in History
While a ton of money has been made in Amazon, Deutsche Bank thinks that there is much more to come in this industry.
Jefferies Top Large Cap Value Stocks to Buy for This Week
It is the best of both worlds for investors when large cap growth companies become inexpensive enough to have a value call.
UBS Makes Big Changes to Equity Focus List for November
A new research report from UBS shows some big changes to this firm's Equity Focus list. It is looking to bring the portfolio's performance up over the final two months of 2015.
Credit Suisse Raises Price Targets on 4 Refining Stocks to Buy
Are the refiners getting up there in valuation? The answer is probably yes, but the companies have pulled back from 52-week highs and are poised to keep the winning ways going.
Credit Suisse Says There Will Be a Winter: 4 Natural Gas Stocks to Buy Now
Credit Suisse reminds investors that of the five El Niño weather events in the past 18 years, only one was warmer than normal, so there's upside to this winter's natural gas market.
4 Top Jefferies Growth Stocks to Buy Right Now
Jefferies continues to track and recommend solid growth stories in which there remains more than ample upside for investors buying shares at current trading levels.
3 Tech Stocks to Own for a Possible End of the Year Rally
A new research report from SunTrust Robinson Humphrey focuses on three top companies that could have significant upside potential for the rest of the year.
Massive Biotech Purchase Highlights Recent Insider Buying
As we are just about through with the spooky month on Wall Street, and the third-quarter earnings are starting to wrap up, one thing we are seeing here is an increase in overall insider…
Huge Intel Sale by Top Executive Highlights Recent Insider Selling
Investors can expect that the volumes of insider buying and selling will continue to increase as we head toward the end of the year.
Merrill Lynch Loves 4 Beaten-Down Clean Energy YieldCos With Huge Distributions
In a new research report, Merrill Lynch expects the recent rally in yieldco valuations to continue. Here are the four top yieldcos that are rated Buy at Merrill Lynch.
3 Tech Stocks to Buy That Are Benefiting From Big Apple Sales
While all these companies have a solid business position as vendor to Apple, they also have very solid overall fundamentals going forward.
3 Stocks to Buy That Got Crushed After Earnings This Quarter
In a new research report, SunTrust Robinson Humphrey has three quality stocks that got pummeled and may be offering investors the best entry point in some time.
Is Long Stock Market Run Over? 4 Late-Cycle Stocks to Buy Now
A new research report from Jefferies details late-cycle stocks that could do well as the aging bull starts to go sideways or trade choppy.
6 Top Specialty Pharmaceutical Stocks to Buy With Over 100% Upside Potential
24/7 Wall St. screened the RBC specialty pharmaceutical universe and found six companies rated Outperform with over 100% upside to the firm's price target.
5 Blue Chip Stocks to Buy That All Yield 4% or More
24/7 Wall St. screened the Merrill Lynch research universe database and found five blue-chip companies currently rated Buy or Neutral that have dividends above 4%.
With Specialty Pharmaceuticals Down Big, 3 to Buy Now for Huge Potential Gains
With specialty pharmaceutical stocks having the chance to move dramatically higher, three large cap leaders are RBC's favorites now.